Sight Sciences (SGHT) EBIT (QoQ) (2020 - 2026)
Sight Sciences (SGHT) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Sight Sciences | 456.76 Mn | 377.01 Mn | 21.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 68.68% |
| Mar 31, 2026 | -238.32% |
| Dec 31, 2025 | 53.59% |
| Sep 30, 2025 | 32.24% |
| Jun 30, 2025 | 15.82% |
| Mar 31, 2025 | -16.18% |
| Dec 31, 2024 | -6.23% |
| Sep 30, 2024 | 11.24% |
| Jun 30, 2024 | 14.07% |
| Mar 31, 2024 | -32.52% |
| Dec 31, 2023 | 17.16% |
| Sep 30, 2023 | 11.69% |
| Jun 30, 2023 | 13.55% |
| Mar 31, 2023 | -3.02% |
| Dec 31, 2022 | 21.94% |
| Sep 30, 2022 | 4.46% |
| Jun 30, 2022 | -3.02% |
| Mar 31, 2022 | -50.81% |
| Dec 31, 2021 | -4.89% |
| Sep 30, 2021 | -26.67% |